CD274 and neoplasm: Indeed, the level of B7-H1 positive TILs have recently been found to be correlated with responses to anti-PD-1 therapy5, 6, suggesting B7-H1 expressing lymphocytes within tumor tissues may determine the final outcome of anti-B7-H1 therapy in human cancers.